Related Experiment Video
Updated: Aug 6, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Schistosome resistance to praziquantel
1Department of Pathology, University of Cambridge, Cambridge, UK. pgf@mole.bio.cam.ac.uk
Abstract:
Praziquantel (PZQ) is the drug of choice for the treatment of human schistosomiasis. In 1994, it was first demonstrated that by sustained drug pressure on a Schistosoma mansoni strain in laboratory conditions resistance to PZQ can develop. Studies in Senegal and Egypt, both schistosomiasis endemic areas, have found that there are schistosome strain(s) that are tolerant to PZQ. In this article evidence from laboratory and field studies regarding the existence of PZQ resistance or tolerant schistosome strain(s) will be examined.
Related Concept Videos
Anthelminthic Agents
Antiprotozoal Agents
Malaria

